Regenesance | Fighting Nerve Degeneration

November, 2010
Regenesance BV receives a seed-stage investment from Life Sciences Fund Amsterdam. See http://www.lsfamsterdam.nl.

August, 2010
Regenesance BV opens Boston office to assist with drug development strategy in the USA

November, 2009
Regenesance BV is founded as a spin-out of the Academic Medical Center (AMC) at the University of Amsterdam.

July, 2009
Dr. Frank Baas and the AMC receive a €250,000 Life Sciences Pre-Seed grant from the Netherlands Genomic Initiative (NGI) to support development of compounds to treat multiple sclerosis. See http://www.preseedgrant.nl/granted_projects.html

June 2008
Frank Baas receives a 100,000 Euro grant from IAmStarter; a pre-seed funding initiative of the AMC at the University of Amsterdam, the Free University & VU Medical Center, and the University of Amsterdam. See www.iamstarter.nl/technostarters-2/regenesance-bv

To learn more about the complement system and its role in nerve damage, please see:

Daha, MR (2010) Role of complement in innate immunity and infections, Crit Rev. Immunol. 2010:30(1):47-52. See www.ncbi.nlm.nih.gov/pubmed/20370619
Ramaglia, V. et al. (2009) Complement inhibition accelerates regeneration in a model of peripheral nerve injury, Mol Immunl. Dec; 47(2-3): 302-9. See www.ncbi.nlm.nih.gov/pubmed/19833392
Ramaglia V. and F. Bass (2009) Innate Immunity in the Nervous System, Prog Brain Res. 175: 95-123. See ww.ncbi.nlm.nih.gov/pubmed/19660651

MEDIA CENTER